Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Erectile Dysfunction × ArginMax × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Radiation Injuries 1 Prostatic Neoplasms 1 Erectile Dysfunction 1

Interventions

udenafil 1 mirabegron 1 bicalutamide 1 alpha-Tocopherol 1 Vitamin E 1 Tamoxifen 1 Tadalafil 1 Sildenafil Citrate 1 Pentoxifylline 1 Long-Term Synaptic Depression 1 GPI 1485 1 Erythropoietin 1 Dutasteride 1 Atorvastatin 1 Arginine 1 ArginMax 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01105130 2021-09-28

L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors

Wake Forest University Health Sciences

Phase 2 Completed

140 enrolled 13 charts

Erectile Dysfunction, Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡